- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CIVITAS SOLUTIONS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 55,96 | -0,94 % | DexCom: Leerink Partners hebt Kursziel wegen rückläufiger G7-Beschwerden an | ||
| PLUS THERAPEUTICS | 0,629 | +0,69 % | Plus Therapeutics Inc.: Plus Therapeutics Expands CNSide Assay Platform to State of California | ||
| CARDINAL HEALTH | 167,80 | -0,39 % | Is Cardinal Health Stock Outperforming the Nasdaq? | ||
| DAVITA | 102,20 | +1,79 % | UBS reiterates Buy rating on DaVita stock, maintains $186 price target | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| DENTSPLY SIRONA | 9,600 | -0,68 % | Dentsply Sirona declares quarterly dividend of $0.16 per share | ||
| CENTENE | 32,770 | -1,21 % | S&P 500 Stocks: UnitedHealth, Centene Rise Amid Push For House ACA Vote | ||
| CYTOSORBENTS | 0,530 | -3,11 % | Cytosorbents Corp: CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update | Third quarter 2025 revenue of $9.5 million, up 10% year-over-year
Amended credit agreement with Avenue Capital Group which strengthens our balance sheet... ► Artikel lesen | |
| COOPER COMPANIES | 68,50 | -0,72 % | Cooper Companies: CFO Brian G. Andrews übernimmt zusätzlich Leitung des Rechnungswesens | ||
| EKSO BIONICS | 4,720 | +1,51 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Third Quarter 2025 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| FULGENT GENETICS | 22,800 | -0,87 % | Raymond James erhöht Kursziel für Fulgent Genetics nach starken Zahlen auf 36 US-Dollar | ||
| IMUNON | 3,260 | -1,81 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| DELCATH SYSTEMS | 8,350 | -2,34 % | Delcath Systems, Inc.: Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress | Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the acceptance of an oral presentation on... ► Artikel lesen | |
| CAREDX | 16,380 | -0,70 % | CareDx, Inc. - 8-K, Current Report | ||
| NUWELLIS, INC | 2,230 | +2,76 % | Nuwellis, Inc.: Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum | MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing... ► Artikel lesen |
Das Unternehmen CIVITAS SOLUTIONS INC kann der Branche Gesundheitswesen zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIVITAS SOLUTIONS INC finden Sie auf Wallstreet Online.